Conjugating an anticancer drug onto thiolated hyaluronic acid by acid liable hydrazone linkage for its gelation and dual stimuli-response release.

[1]  A. Noronha,et al.  Reductively-sheddable cationic nanocarriers for dual chemotherapy and gene therapy with enhanced release. , 2015, Colloids and surfaces. B, Biointerfaces.

[2]  S. Goldring,et al.  A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[3]  J. Oh,et al.  Glutathione-triggered disassembly of dual disulfide located degradable nanocarriers of polylactide-based block copolymers for rapid drug release. , 2014, Biomacromolecules.

[4]  Mousumi Bhattacharyya,et al.  Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxel. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[5]  Jian-tao Lin,et al.  A macromolecular prodrug strategy for combinatorial drug delivery. , 2014, Journal of colloid and interface science.

[6]  Ashok Kumar,et al.  Gellan-thioglycolic acid conjugate: synthesis, characterization and evaluation as mucoadhesive polymer. , 2014, Carbohydrate polymers.

[7]  Ru Cheng,et al.  Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy , 2013, Expert opinion on drug delivery.

[8]  Kinam Park,et al.  Development of an in vitro 3D tumor model to study therapeutic efficiency of an anticancer drug. , 2013, Molecular pharmaceutics.

[9]  Lixin Liu,et al.  International Journal of Pharmaceutics Supramolecular Hydrogels as a Universal Scaffold for Stepwise Delivering Dox and Dox/cisplatin Loaded Block Copolymer Micelles , 2022 .

[10]  Bin Lai,et al.  Synthesis of disulfide-cross-linked polypeptide nanogel conjugated with a near-infrared fluorescence probe for direct imaging of reduction-induced drug release. , 2012, ACS applied materials & interfaces.

[11]  U. Ritz,et al.  Photocrosslinkable dextran hydrogel films as substrates for osteoblast and endothelial cell growth , 2012 .

[12]  Z. Shao,et al.  Injectable thixotropic hydrogel comprising regenerated silk fibroin and hydroxypropylcellulose , 2012 .

[13]  Li‐Ming Zhang,et al.  Supramolecular gelation of a polymeric prodrug for its encapsulation and sustained release. , 2011, Biomacromolecules.

[14]  Min Wu,et al.  Release of hydrophobic anticancer drug from a newly designed self-assembling peptide. , 2011, Molecular bioSystems.

[15]  Yongfeng Zhou,et al.  Bioreducible micelles self-assembled from amphiphilic hyperbranched multiarm copolymer for glutathione-mediated intracellular drug delivery. , 2011, Biomacromolecules.

[16]  H. Ijima,et al.  In situ gellable oxidized citrus pectin for localized delivery of anticancer drugs and prevention of homotypic cancer cell aggregation. , 2010, Biomacromolecules.

[17]  Mark E. Davis,et al.  Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin. , 2009, Advanced drug delivery reviews.

[18]  Xiang Cai,et al.  Synthesis and anaerobic biodegradation of indomethacin-conjugated cellulose ethers used for colon-specific drug delivery. , 2009, Bioresource technology.

[19]  C. Zheng,et al.  Disulfide-crosslinked chitosan hydrogel for cell viability and controlled protein release. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  J. Hilborn,et al.  In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach. , 2009, Journal of the American Chemical Society.

[21]  Antonios G Mikos,et al.  Injectable matrices and scaffolds for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[22]  I. Ojima,et al.  Recent advances in tumor-targeting anticancer drug conjugates. , 2005, Bioorganic & medicinal chemistry.

[23]  L. Gianni,et al.  Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.

[24]  K. Ulbrich,et al.  Polymeric anticancer drugs with pH-controlled activation. , 2004, Advanced drug delivery reviews.

[25]  Glenn D Prestwich,et al.  Disulfide cross-linked hyaluronan hydrogels. , 2002, Biomacromolecules.

[26]  M. Tammi,et al.  Hyaluronan-Cell Interactions in Cancer and Vascular Disease* , 2002, The Journal of Biological Chemistry.

[27]  D J Mooney,et al.  Sustained and controlled release of daunomycin from cross-linked poly(aldehyde guluronate) hydrogels. , 2000, Journal of pharmaceutical sciences.

[28]  Yoshito Ikada,et al.  Crosslinking of hyaluronic acid with glutaraldehyde , 1997 .

[29]  F. Nicolas,et al.  Denatured thiolated collagen. II. Cross-linking by oxidation. , 1997, Biomaterials.

[30]  F. Nicolas,et al.  Denatured thiolated collagen. I. Synthesis and characterization. , 1997, Biomaterials.

[31]  R. Lowenthal,et al.  Toxicity of chemotherapy. , 1996, Hematology/oncology clinics of North America.

[32]  Bing Zheng,et al.  New heparin-indomethacin conjugate with an ester linkage: synthesis, self aggregation and drug delivery behavior. , 2014, Materials science & engineering. C, Materials for biological applications.

[33]  S. Pham,et al.  Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model. , 2009, Acta biomaterialia.